glp 1 agonists vs sglt2 inhibitors GLP-1 Receptor Agonist Therapy With and Without in Patients With Type 2 Diabetes Role of GLP-1 Agonists &

Scheen has received lecturer/scientific advisor/clinical investigator fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, and NovoNordisk, and has worked as a clinical investigator in the EMPA-REG OUTCOME, CANVAS-R, DECLARE-TIMI 58, LEADER and HARMONY Outcomes cardiovascular outcome trials

Amylase Test Lipase Test Vitamin Tests: These are essential for detecting nutrient deficiencies, as GLP-1 medications may suppress appetite and reduce overall nutrient intake 13

GLP-1 drugs such as Ozempic, Wegovy, and Zepbound have transformed obesity treatment, helping millions lose significant weight

J Investig Med 66:710

Endogenous glucagon-like peptide-1 suppresses high-fat food intake by reducing synaptic drive onto mesolimbic dopamine neurons

When caloric intake decreases, the body compensates by slowing metabolism and increasing hunger signals, making sustained weight loss difficult for many individuals